WETS
RPRX icon

Wealth Enhancement Trust Services’s Royalty Pharma RPRX Stock Holding History

Wealth Enhancement Trust Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
+403
New +$21K ﹤0.01% 605
2026
Q1 		– Sell
-109
Closed -$4.21K – 815
2025
Q4 		$4.21K Buy
+109
New +$4.16K ﹤0.01% 610

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wealth Enhancement Trust Services's RPRX Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Royalty Pharma (RPRX) in Q2 2026: 403 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #605 among its holdings. This is a return to the name: Wealth Enhancement Trust Services previously reported a position in RPRX as recently as Q4 2025.

Wealth Enhancement Trust Services first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 498 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Wealth Enhancement Trust Services held 403 shares of Royalty Pharma worth $22.6K as of Q2 2026.
  • Royalty Pharma was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #605 holding.
  • Wealth Enhancement Trust Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 498 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.